Stay updated on Neoadj Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the Neoadj Pembrolizumab Clinical Trial page.

Latest updates to the Neoadj Pembrolizumab Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedStatus updated from Active, not recruiting to Completed with the actual completion date; page revision updated to v3.5.0.SummaryDifference0.4%

- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedPage revision updated to v3.4.3, replacing the previous v3.4.2 revision.SummaryDifference0.1%

- Check53 days agoChange DetectedThe revision label changed from v3.4.1 to v3.4.2, with no visible changes to content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision from v3.4.0 to v3.4.1 is shown; core study details and layout appear unchanged.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision: v3.3.4 replaces the previous v3.3.3. This update does not modify study details or core page content.SummaryDifference0.1%

- Check104 days agoChange DetectedAdded a Locations section with Minnesota, New Hampshire, and North Carolina. Removed the HHS Vulnerability Disclosure link and updated the page revision from v3.3.2 to v3.3.3.SummaryDifference0.4%

Stay in the know with updates to Neoadj Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neoadj Pembrolizumab Clinical Trial page.